vcfirmsdirectory.com

Venture capital

LUMIRA VENTURES

Lumira Ventures is a North American life sciences venture capital firm headquartered in Toronto. It backs therapeutic and medical device companies, with offices in Toronto, Montréal, Vancouver and Boston.

Toronto, OntarioRegistered · Toronto, Ontario
New investments · 12 months
Fund vehiclesPublic
8
8 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 8 Nov 2026, 05:38 CETSources: lumiraventures.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round LUMIRA VENTURES joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is LUMIRA VENTURES right for your round?

Is LUMIRA VENTURES a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
8
8 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

LUMIRA VENTURES IV (INTERNATIONAL), L.P.US private fund · Active · Canada · $26.7M gross assets · filed 30 Mar 2026
MERCK LUMIRA BIOSCIENCES FUND, L.P.US private fund · Active · Canada · $25.3M gross assets · filed 30 Mar 2026
LUMIRA VENTURES III (INTERNATIONAL), L.P.US private fund · Active · Canada · $5M gross assets · filed 30 Mar 2026
LUMIRA VENTURES IV HOLDING LPUS private fund · Active · Canada · $4.5M gross assets · filed 30 Mar 2026
LUMIRA CAPITAL II (INTERNATIONAL), L.P.US private fund · Active · Canada · $4.3M gross assets · filed 30 Mar 2026
LUMIRA CAPITAL GP, L.P.US private fund · Active · Canada · $394K gross assets · filed 30 Mar 2026
LUMIRA VENTURES III GP, L.P.US private fund · Active · Canada · $350K gross assets · filed 30 Mar 2026
LUMIRA CAPITAL (USA), L.P.US private fund · Active · United States · $17.8K gross assets · filed 30 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds LUMIRA VENTURES joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

1 round in the last 12 months

Round sizes, LUMIRA VENTURES’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

AlveolusAurinia PharmaceuticalsBardyDxCeption TherapeuticsCorus PharmaceuticalsDepomedEdesa BiotechEndotronixEngage TherapeuticsESSA Pharmaand 50 more

Portfolio and exits

Every company LUMIRA VENTURES backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where LUMIRA VENTURES puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet LUMIRA VENTURES

Events where LUMIRA VENTURES’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet LUMIRA VENTURES’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

18 Jun 2026New deal
30 Mar 2026Fund filingForm ADV filed by LUMIRA VENTURES: 8 private funds, $66.6M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

LUMIRA VENTURES is based in Toronto, Ontario, Canada.

8 fund vehicles are on public registers (SEC adviser filings), including LUMIRA VENTURES IV (INTERNATIONAL), L.P., MERCK LUMIRA BIOSCIENCES FUND, L.P. and LUMIRA VENTURES III (INTERNATIONAL), L.P.

Sectors: Life sciences, Medtech. From the firm’s own website.

Lumira partners with mission-driven founders to build life sciences companies that develop and commercialize products for patients. It invests in therapeutics and medical devices addressing high unmet clinical need, across the stage continuum, aiming to break down barriers, improve outcomes and reduce costs. From the firm’s own website.

LUMIRA VENTURES lists 60 portfolio companies on its website, including Alveolus, Aurinia Pharmaceuticals, BardyDx, Ception Therapeutics and Corus Pharmaceuticals.

Firms whose websites list some of the same companies include Aperture Venture Partners, RA Capital and Iaso Ventures.

Know before LUMIRA VENTURES’s next round is announced.

PRO tracks LUMIRA VENTURES’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

LUMIRA VENTURESGet LUMIRA VENTURES’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.